Minnesota 2023-2024 Regular Session

Minnesota Senate Bill SF329

Introduced
1/17/23  
Refer
1/17/23  
Refer
2/13/23  

Caption

No-cost diagnostic services and testing requirement following a mammogram

Impact

If enacted, SF329 would significantly alter the landscape of health insurance coverage in Minnesota. Specifically, it would eliminate out-of-pocket expenses such as co-pays, deductibles, or coinsurance for necessary diagnostic services post-mammogram, thereby enhancing access to critical follow-up care for patients. This change is expected to encourage women to seek necessary reconfirmation or additional tests after mammograms without the burden of financial barriers, likely leading to earlier detection and treatment of potential health issues.

Summary

SF329 is a legislative measure aimed at requiring health insurance providers in Minnesota to offer coverage for additional diagnostic services or testing following a mammogram without imposing any cost-sharing on the insured individuals. This mandate applies specifically when a healthcare provider determines further testing is necessary for the patient. The effective date for this coverage requirement is set to January 1, 2024, applying to all health plans offered, issued, or sold after this date. The bill amends several sections of the Minnesota Statutes, thereby reinforcing the state's commitment to preventative healthcare measures.

Sentiment

The sentiment around SF329 appears largely positive among healthcare advocates and legislators focused on women's health. Supporters argue that this bill aligns with broader goals of improving health outcomes by making follow-up care more accessible and removing cost barriers that might deter patients from seeking necessary medical interventions. On the other hand, opponents might raise concerns about the financial implications for health insurers and potential increases in premiums, as comprehensive no-cost coverage can impact overall health plan economics.

Contention

Despite overall support, SF329 may face contention related to its financial implications for health plans. Critics could argue that mandating no-cost coverage for additional diagnostic services may lead to higher operational costs for insurance providers, potentially shifting expenses to consumers in the form of increased premiums. Furthermore, debates may arise around who bears the responsibility for ensuring these services are adequately funded within existing healthcare budgets, which can lead to discussions about the sustainability of such broad healthcare policies in the long term.

Companion Bills

MN HF390

Similar To No-cost diagnostic services and testing required following mammogram.

Similar Bills

CA AB516

Sex offenses: disabled victims.

CA AB2123

District-based elections.

CA AB453

District-based elections.

CA AB3171

Controlled substances: fentanyl.

MI HB4122

Health occupations: health professionals; permanent revocation of license or registration if convicted of sexual conduct under pretext of medical treatment; provide for. Amends sec. 16226 of 1978 PA 368 (MCL 333.16226). TIE BAR WITH: HB 4121'23

CA AB892

Sex offenders: registration: solicitation of a minor.

CA SB680

Sex offender registration: unlawful sexual intercourse with a minor.

MN SF1826

Payment rates establishment for certain substance use disorder treatment services